Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty. - Test2 - elhamkhani - TriplyDB

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.

http://www.wikidata.org/entity/Q37569325

about

Safety of new oral anticoagulant drugs: a perspective The potential benefits of low-molecular-weight heparins in cancer patients Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor.Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery.Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.Dabigatran induced hemorrhagic cystitis in a patient with painful bladder syndrome.Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.New anticoagulants: A concise review.New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty.Oral antithrombotic inhibitors: dabigatran etexilate, meeting an unmet need?

P2860

Q27016072-D907AC89-7A96-4CAC-A3C3-8F28F500BFD2 Q33698360-59E34915-B1F0-4F52-9833-00371F67E9DE Q34611004-7F2C842E-FCE0-4367-953C-7788CF7F0F4F Q35536242-A568BF81-BD54-40E5-A581-A71F8071B919 Q37472172-082C9545-1A4E-4FDD-96C2-37E47F42F571 Q37679709-76D64A09-E35B-484A-8226-8236C148656F Q37834393-103FF186-9F25-4D2A-A3A0-81EF06764365 Q37900217-05994222-BD64-4FB5-802F-AB3FBCA18A23 Q38043378-C8F3AB49-6B8D-4BCE-83B5-864FB59A62D9 Q38988927-5A94742E-0540-470C-91CC-A71DECB8EF3B Q43286263-B44D38B4-9E1B-485D-BBC8-43B2EB21BD68

P2860

Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.

http://www.wikidata.org/entity/Q37569325

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@en

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@nl

type

label

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@en

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@nl

prefLabel

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@en

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@nl

P1433

Q37569325-DBE1276F-B2F9-4AB0-83AB-77E6600CE0DC

P1476

Q37569325-F1A91CF8-3768-4F9A-B793-81384EE827AD

P2093

Q37569325-936F9337-CAE8-490A-9D96-67141081D984

Q37569325-F933CC02-DDE2-41B0-87DD-B39D56A211E9

P2860

Q37569325-3C5DD481-CE96-4FD5-B556-BD1A1CDB8501

Q37569325-407A066C-CE56-46BF-9B6A-03352F99E386

Q37569325-475D82AF-829A-4CD3-9A4B-5D6D1486079E

Q37569325-56E669C7-C7EB-49B9-86B6-8F1F30C28CDA

Q37569325-5812D49D-C855-4FBD-B629-1FE36FAFDD02

Q37569325-64E4D998-2514-493F-8D74-5B5263D3B524

Q37569325-70D3500C-B5A3-4262-910D-FF1F24045338

Q37569325-B7906003-B4C2-48BF-9802-5CA8048DD2A5

Q37569325-D153512D-20C8-49D1-A5F7-500524982953

P304

Q37569325-747E1E1C-77A0-47A4-8384-514EAB1228D1

P31

Q37569325-B862953D-8275-4906-A6C3-52FEC12E9544

P356

Q37569325-7A9A754E-2CDB-4B68-997B-3D38B758C8EA

P478

Q37569325-0D4DEB91-B178-49C0-AF1F-A025427A1B28

P577

Q37569325-9F76F34C-0A1D-4DD0-A082-A764B2602172

P698

Q37569325-4097F700-A385-41EC-80C2-5FEAA4B8D875

P356

1076029609340668

P1433

Clinical and Applied Thrombosis-Hemostasis

P1476

Dabigatran etexilate: pivotal ...... fter hip or knee arthroplasty.

@en

P2093

Bengt I Eriksson

http://www.w3.org/2001/XMLSchema#string

Richard J Friedman

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-based design of novel potent nonpeptide thrombin inhibitors

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis.

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

P304

25S-31S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029609340668

http://www.w3.org/2001/XMLSchema#string

P478

15 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19648146

http://www.w3.org/2001/XMLSchema#string